Can't find prescription drugs at ASP? You have few options

Article Overview

This article covers concerns about the availability of Medicare Part B drugs at average sales price (ASP) levels and the response from CMS and physician organizations. It is relevant to physicians, practice managers, coders, and reimbursement staff who track drug pricing, Medicare payment policy, and access to infused and injectable drugs. The article summarizes the kinds of pricing complaints being reported, the organizations monitoring the issue, and the general Medicare administrative contacts suggested for addressing pricing problems.